慢性血透患者甲状旁腺次全切除术后肌肉力量与代谢变化的前瞻性研究
该前瞻性自身前后对照研究纳入23例因继发性甲状旁腺功能亢进而行甲状旁腺次全切除术的慢性血透患者,评估术后代谢指标、体成分、肌力及生活质量变化。术后甲状旁腺激素显著下降,血浆总蛋白、白蛋白、前白蛋白及握力、生活质量部分维度均改善。10年随访时约三分之一死亡、三分之一复发、三分之一接受肾移植。
要点
- 慢性血透患者术前握力较正常下降52.4±17%,提示肌力损害常见。
- 甲状旁腺次全切除术后1和6个月,甲状旁腺激素、血浆蛋白及握力均显著改善。
- 术后10年约三分之一患者死亡、三分之一复发、三分之一肾移植后甲状旁腺功能正常。
核心结论
- 甲状旁腺次全切除术可改善慢性血透患者的蛋白质代谢标志物、肌肉力量和躯体功能。
研究设计与样本
- 前瞻性观察性自身前后对照研究,连续纳入23例因继发性甲状旁腺功能亢进转诊行甲状旁腺次全切除术的慢性血透患者。
- 术前基线及术后1个月、6个月评估代谢参数、生物电阻抗体成分、肌力和生活质量(36项短表健康调查问卷)。
- 随访终点为继发性甲状旁腺功能亢进复发、肾移植或死亡。
主要发现
- 术前握力下降52.4±17%。
- 术后免疫反应性甲状旁腺激素浓度由1153 pg/mL降至237 pg/mL(P < .001)。
- 血浆总蛋白由6.8 g/dL升至7.8 g/dL,白蛋白由3.7 g/dL升至4.4 g/dL,前白蛋白由31.7 mg/dL升至35.2 mg/dL(P < .001)。
- 握力由18.3 kg升至22.9 kg(P = .001)。
- 36项短表健康调查问卷躯体维度由32.9升至35.6(P = .004),活力维度由32.3升至47.1(P = .002)。
临床怎么用
- 对慢性血透继发性甲状旁腺功能亢进患者,甲状旁腺次全切除术除控制甲状旁腺激素外,可能改善营养相关蛋白指标和肌力。
- 围术期及术后随访中可关注握力、血浆蛋白及生活质量变化,作为评估手术获益的补充指标。
局限性
- 样本量较小(23例),为单中心前瞻性观察性自身前后对照研究,无对照组。
- 随访终点包含肾移植和死亡,可能影响长期结局解释。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hyperparathyroidism in patients on chronic hemodialysis presents with bone pain, pruritus, and extra-skeletal calcifications. Little attention has been paid to low plasma protein concentrations and muscle weakness in these patients. The present study was undertaken to characterize the impact of subtotal parathyroidectomy for chronic hemodialysis on body composition, muscle strength, plasma proteins, quality of life, and long-term clinical course. METHODS: We performed a prospective observational before-after assessment study of consecutive chronic hemodialysis patients referred for parathyroidectomy. Patients were investigated at baseline before parathyroidectomy and then at 1 and 6 months after surgery, with the aim to assess changes in metabolic parameters, body composition by bioimpedance, muscle strength, and quality of life (36-items Short Form Health Survey questionnaire). Follow-up was terminated when patients reached 1 of the 3 pre-defined end points: recurrence of secondary hyperparathyroidism, transplantation, or death. RESULTS: A group of 23 patients on hemodialysis were included. Preoperative handgrip strength was diminished by 52.4 ± 17%. After parathyroidectomy, a drop of immunoreactive parathyroid hormone concentrations (1,153 vs 237 pg/mL; P < .001) was observed together with increases in plasma protein (total: 6.8 vs7.8 g/dL, s-albumin 3.7 vs 4.4 g/dL and prealbumin: 31.7 vs 35.2 mg/dL; P < .001), handgrip strength (18.3 vs 22.9 kg: P = .001) as well as an improvement in physical dimension (32.9 vs 35.6; P = .004) and vitality (32.3 vs 47.1; P = .002) domains of the 36-items Short Form Health Survey questionnaire. After10 years, one-third of the patients had died, one-third of the patients had a recurrence of secondary hyperparathyroidism, and one-third of patients had received a kidney transplant and maintained a normal parathyroid function. CONCLUSION: Subtotal parathyroidectomy improves protein metabolic markers, muscle strength, and physical performance in chronic hemodialysis patients.
引用
- Jimeno-Fraile J, Cao H, Sancho-Insenser J, et al. Muscle strength, physical performance, and metabolic changes after subtotal parathyroidectomy for secondary hyperparathyroidism. Surgery. 2020. PMID: 33218703. doi:10.1016/j.surg.2020.10.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。